| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
24,016 |
23,144 |
$2.80M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
19,921 |
19,343 |
$2.79M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
13,791 |
13,267 |
$1.79M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
7,654 |
6,861 |
$1.77M |
| 59025 |
Fetal non-stress test |
3,435 |
2,066 |
$663K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,211 |
2,187 |
$648K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,731 |
1,700 |
$503K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,827 |
1,807 |
$441K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,854 |
2,797 |
$414K |
| 80053 |
Comprehensive metabolic panel |
14,128 |
12,977 |
$348K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,550 |
1,507 |
$309K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
5,706 |
5,551 |
$274K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
4,007 |
1,364 |
$272K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
901 |
895 |
$263K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
344 |
343 |
$234K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
3,823 |
3,760 |
$186K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
271 |
269 |
$185K |
| 99215 |
Prolong outpt/office vis |
1,503 |
1,164 |
$175K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
558 |
552 |
$173K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,154 |
871 |
$130K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
1,653 |
1,325 |
$130K |
| 76770 |
|
609 |
602 |
$126K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
384 |
383 |
$121K |
| 36415 |
Collection of venous blood by venipuncture |
18,582 |
16,006 |
$118K |
| 87631 |
|
1,852 |
1,812 |
$114K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,677 |
4,185 |
$109K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,591 |
1,591 |
$96K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
1,122 |
1,119 |
$74K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
943 |
766 |
$61K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
350 |
332 |
$54K |
| 97161 |
|
626 |
617 |
$52K |
| 76830 |
Ultrasound, transvaginal |
1,184 |
1,178 |
$46K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
933 |
908 |
$46K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,241 |
2,786 |
$45K |
| 86850 |
|
1,155 |
1,115 |
$45K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
121 |
120 |
$41K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,053 |
1,040 |
$39K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
307 |
257 |
$35K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
588 |
586 |
$34K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
107 |
107 |
$33K |
| 86901 |
|
1,213 |
1,170 |
$32K |
| 12001 |
|
69 |
69 |
$30K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
332 |
328 |
$29K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
109 |
108 |
$29K |
| 87634 |
|
1,227 |
1,216 |
$29K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
4,036 |
3,954 |
$28K |
| G0378 |
Hospital observation service, per hour |
117 |
116 |
$26K |
| 86900 |
|
1,203 |
1,161 |
$25K |
| 99233 |
Prolong inpt eval add15 m |
374 |
180 |
$25K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
573 |
553 |
$23K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,084 |
1,070 |
$23K |
| 83880 |
|
654 |
626 |
$21K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
13 |
13 |
$20K |
| 71046 |
Radiologic examination, chest; 2 views |
2,543 |
2,504 |
$20K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
51 |
50 |
$17K |
| 93971 |
|
161 |
160 |
$16K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
703 |
285 |
$16K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
213 |
212 |
$15K |
| 94060 |
|
219 |
219 |
$12K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,520 |
2,218 |
$11K |
| 71250 |
|
127 |
127 |
$11K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,434 |
1,409 |
$11K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
68 |
66 |
$10K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,344 |
1,344 |
$9K |
| 76801 |
|
78 |
75 |
$9K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,917 |
1,778 |
$8K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
5,193 |
4,515 |
$8K |
| 94727 |
|
451 |
451 |
$7K |
| 80076 |
|
567 |
550 |
$7K |
| 72141 |
|
24 |
24 |
$7K |
| 94729 |
|
518 |
518 |
$7K |
| 81025 |
|
2,046 |
2,027 |
$7K |
| 71271 |
|
247 |
247 |
$5K |
| 85610 |
|
1,342 |
1,244 |
$5K |
| 84443 |
Thyroid stimulating hormone (TSH) |
693 |
671 |
$5K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
29 |
24 |
$5K |
| 82803 |
|
146 |
137 |
$5K |
| 76536 |
|
220 |
216 |
$5K |
| 90715 |
|
155 |
155 |
$5K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,372 |
1,294 |
$5K |
| 72110 |
|
210 |
210 |
$4K |
| 71045 |
Radiologic examination, chest; single view |
485 |
474 |
$4K |
| 88304 |
|
54 |
53 |
$4K |
| 87081 |
|
947 |
938 |
$4K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
72 |
49 |
$4K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
120 |
116 |
$4K |
| 70496 |
|
13 |
13 |
$4K |
| 84484 |
|
2,109 |
1,174 |
$3K |
| 74018 |
|
290 |
275 |
$3K |
| 80061 |
Lipid panel |
254 |
251 |
$3K |
| 77080 |
|
46 |
46 |
$3K |
| 80050 |
General health panel |
78 |
76 |
$2K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
12 |
12 |
$2K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,177 |
1,065 |
$2K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
69 |
69 |
$2K |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
52 |
52 |
$2K |
| 81001 |
|
1,700 |
1,599 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
249 |
244 |
$1K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
20 |
19 |
$1K |
| 85027 |
|
334 |
315 |
$1K |
| 84702 |
|
1,489 |
1,386 |
$1K |
| 76642 |
|
51 |
51 |
$956.13 |
| 83690 |
|
1,672 |
1,539 |
$912.02 |
| 87040 |
|
37 |
26 |
$804.04 |
| 83735 |
|
445 |
394 |
$742.59 |
| 81003 |
|
947 |
917 |
$502.09 |
| 87186 |
|
102 |
93 |
$465.12 |
| 73630 |
|
63 |
59 |
$380.14 |
| 73564 |
|
13 |
13 |
$323.55 |
| 76641 |
|
14 |
14 |
$284.40 |
| 73130 |
|
31 |
28 |
$283.27 |
| 73610 |
|
28 |
28 |
$279.87 |
| 87660 |
|
27 |
27 |
$270.93 |
| 87480 |
|
26 |
26 |
$254.89 |
| 87510 |
|
25 |
25 |
$237.45 |
| 84132 |
|
50 |
50 |
$236.04 |
| 82565 |
|
39 |
39 |
$206.22 |
| 82607 |
|
13 |
13 |
$184.73 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,937 |
1,260 |
$174.20 |
| 73030 |
|
13 |
12 |
$145.78 |
| 73110 |
|
15 |
14 |
$127.54 |
| 73502 |
|
14 |
13 |
$126.78 |
| 87077 |
|
43 |
38 |
$123.25 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
771 |
759 |
$113.53 |
| 80306 |
|
123 |
116 |
$104.86 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
14 |
14 |
$72.38 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,380 |
1,255 |
$59.12 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
826 |
816 |
$50.21 |
| 87430 |
|
59 |
57 |
$44.37 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
593 |
579 |
$40.23 |
| 86140 |
|
13 |
13 |
$10.26 |
| 85652 |
|
12 |
12 |
$5.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
95 |
89 |
$3.92 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
12 |
12 |
$1.13 |
| 83605 |
|
14 |
13 |
$0.47 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
36 |
25 |
$0.05 |